---
title: "The pharmaceutical commercial sector saw a short-term surge, with HRPC hitting the daily limit"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292693935.md"
description: "The pharmaceutical commercial sector saw a short-term surge, with HRPC hitting the limit up, followed by Hezong Medicine Easy-To-Buy Pharmaceutical, Baheal Medical, Huaren Health, LUYAN PHARMA, and SYPM all rising"
datetime: "2026-07-15T01:38:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292693935.md)
  - [en](https://longbridge.com/en/news/292693935.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292693935.md)
generator: "portal-rs"
---

# The pharmaceutical commercial sector saw a short-term surge, with HRPC hitting the daily limit

The pharmaceutical commercial sector saw a short-term surge, with HRPC hitting the limit up, followed by Hezong Medicine Easy-To-Buy Pharmaceutical, Baheal Medical, Huaren Health, LUYAN PHARMA, and SYPM also rising

### Related Stocks

- [002788.CN](https://longbridge.com/en/quote/002788.CN.md)
- [300937.CN](https://longbridge.com/en/quote/300937.CN.md)
- [301408.CN](https://longbridge.com/en/quote/301408.CN.md)
- [301015.CN](https://longbridge.com/en/quote/301015.CN.md)
- [301017.CN](https://longbridge.com/en/quote/301017.CN.md)
- [600829.CN](https://longbridge.com/en/quote/600829.CN.md)

## Related News & Research

- [Beijing Biostar Boosts Strategic Ties With Baheal via HK$100 Million Share Subscription](https://longbridge.com/en/news/285580818.md)
- [The unhelpful nationalism of ‘Buy British’ in defence](https://longbridge.com/en/news/297465532.md)
- [Echo Base Forms BitMart Claimholder Group Following Bankruptcy Restructuring Proposal](https://longbridge.com/en/news/297817061.md)
- [CIF/FOB Gulf Grain-US Gulf corn and soybean CIF values decline](https://longbridge.com/en/news/297836811.md)
- [08:27 ETHyGen Promotes Omid Ghobadi to Chief Operating Officer](https://longbridge.com/en/news/297786116.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**